Table 3: Healthcare Usage at 3 Years in the EARLY-AF Trial.
| ER Visit | Hospitalisation | Cardioversion | Non-protocol Ablation |
|---|---|---|---|
| RR 0.84, 95% CI [0.59–1.20] | RR 0.3, 95% CI 1 [0.14–0.66] | RR 0.68, 95% CI [0.36–1.29] | RR 0.41, 95% CI [0.28–0.61] |
| Ablation 40 (26.0%) versus AAD 46 (30.9%) |
Ablation 8 (5.2%) versus AAD 25 (16.8%) |
Ablation 14 (9.1%) versus AAD 20 (13.4%) |
Ablation 27 (17.5%) versus AAD 63 (42.3%) |
AAD = antiarrhythmic drugs.